Home >> Research Area >>Others>>Imidazoline Receptors>> Rilmenidine Phosphate

Rilmenidine Phosphate

antihypertensive drug targets the imidazoline receptor CAS# 85409-38-7

Rilmenidine Phosphate

2D Structure

Catalog No. BCC5637----Order now to get a substantial discount!

Product Name & Size Price Stock
Rilmenidine Phosphate: 5mg $81 In Stock
Rilmenidine Phosphate: 10mg Please Inquire In Stock
Rilmenidine Phosphate: 20mg Please Inquire Please Inquire
Rilmenidine Phosphate: 50mg Please Inquire Please Inquire
Rilmenidine Phosphate: 100mg Please Inquire Please Inquire
Rilmenidine Phosphate: 200mg Please Inquire Please Inquire
Rilmenidine Phosphate: 500mg Please Inquire Please Inquire
Rilmenidine Phosphate: 1000mg Please Inquire Please Inquire
Related Products
  • Ro3280

    Catalog No.:BCC3962
    CAS No.:1062243-51-9
  • MLN0905

    Catalog No.:BCC3961
    CAS No.:1228960-69-7
  • Rigosertib

    Catalog No.:BCC4296
    CAS No.:592542-59-1
  • Rigosertib sodium

    Catalog No.:BCC4067
    CAS No.:592542-60-4
  • GW843682X

    Catalog No.:BCC1614
    CAS No.:660868-91-7
  • GSK461364

    Catalog No.:BCC3788
    CAS No.:929095-18-1

Quality Control of Rilmenidine Phosphate

3D structure

Package In Stock

Rilmenidine Phosphate

Number of papers citing our products

Chemical Properties of Rilmenidine Phosphate

Cas No. 85409-38-7 SDF Download SDF
PubChem ID 198614 Appearance Powder
Formula C10H19N2O5P M.Wt 278.24
Type of Compound N/A Storage Desiccate at -20°C
Solubility >5.68mg/mL in DMSO
Chemical Name N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine;phosphoric acid
SMILES C1CC1C(C2CC2)NC3=NCCO3.OP(=O)(O)O
Standard InChIKey ZJCOWRFWZOAVFY-UHFFFAOYSA-N
Standard InChI InChI=1S/C10H16N2O.H3O4P/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10;1-5(2,3)4/h7-9H,1-6H2,(H,11,12);(H3,1,2,3,4)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Rilmenidine Phosphate Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Rilmenidine Phosphate Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Rilmenidine Phosphate

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.594 mL 17.9701 mL 35.9402 mL 71.8804 mL 89.8505 mL
5 mM 0.7188 mL 3.594 mL 7.188 mL 14.3761 mL 17.9701 mL
10 mM 0.3594 mL 1.797 mL 3.594 mL 7.188 mL 8.985 mL
50 mM 0.0719 mL 0.3594 mL 0.7188 mL 1.4376 mL 1.797 mL
100 mM 0.0359 mL 0.1797 mL 0.3594 mL 0.7188 mL 0.8985 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Rilmenidine Phosphate

Rilmenidine phosphate is the water soluble form of Rilmenidine. It is an antihypertensive drug targets the imidazoline receptor. [1]
Imidazoline receptor is a family of non-adrenergic high affinity binding site for clonidine, idazoxan, and other imidazoline drugs. [2] There are three types of imidazoline receptor. I-1 mediates sympatho-inhibitory actions to the lower blood pressure; I-2 is allosteric binding site of monamine oxidase and I-3 controls insulin secretion of pancreatic cells. [3]
In Hep G2 cells treated with 0.5 mM oleic acid for 6 hours and 1μm Rilmenidine for 30 minutes, the oleic acid-induced lipid accumulation decreases. [4] Stimulation of imidazoline I-1 receptor by Rilmenidine activated P38 to induce the expression of FXR. [4]
Mice fed with HFD (high fat diet) had improved hepatic steatosis following the administration of Rilmenidien through the activation of imidazoline I-1 receptor. [4] Imidazoline receptors are involved in the bulbospinal regulation of blood pressure and affect peripheral stimulation. [1] In hypertensive patients, Rilmenidine decreased blood pressure in a dose-dependent mater. In contrast with placebo, Rilmenidine had significantly lowered blood pressures. In addition, Rilmenidine had significantly less incidences of adverse effects than using other drugs for hypertension. [1]
References:
[1] Laurent S, Safar M. Rilmenidine: a novel approach to first-line treatment of hypertension. Am J Hypertens. 1992 Apr;5(4 Pt 2):99S-105S.
[2] Regunathan S, Reis DJ. Imidazoline receptors and their endogenous ligands.Annu Rev Pharmacol Toxicol. 1996;36:511-44.
[3] Head GA, Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem. 2006 Jan;4(1):17-32.
[4] Yang PS, Wu HT, Chung HH, Chen CT, Chi CW, Yeh CH, Cheng JT. Rilmenidine improves hepatic steatosis through p38-dependent pathway to higher the expression of farnesoid X receptor. Naunyn Schmiedebergs Arch Pharmacol. 2012 Jan;385(1):51-6.

Featured Products
New Products
 

Description

Rilmenidine Phosphate is a selective I(1) imidazoline receptor agonist, used for the treatment of hypertension.

Keywords:

Rilmenidine Phosphate,85409-38-7,Natural Products,Imidazoline Receptors, buy Rilmenidine Phosphate , Rilmenidine Phosphate supplier , purchase Rilmenidine Phosphate , Rilmenidine Phosphate cost , Rilmenidine Phosphate manufacturer , order Rilmenidine Phosphate , high purity Rilmenidine Phosphate

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: